Scientists discover how a killer fungus attacks HIV patients

Researchers have discovered that a type of white blood cell carries a deadly fungus into the brains of HIV positive patients, causing meningitis which kills more than 600,000 people a year.

The discovery could lead to more effective ways of tackling the as it infects the human body.

Globally, 1.6 million people died of AIDS-related illnesses worldwide in 2012 according to the World Health Organisation.

Researchers at St George's, University of London and the University of Birmingham tested 65 strains of the fungus Cryptococcus which had been collected from HIV positive patients enrolled in clinical trials by the St George's group.

Their aim was to find out what leads certain patients to have higher amounts of the fungus in their – a key indicator of likelihood of death.

This new study shows that fungal strains that are more easily engulfed by , called macrophages, go on to cause a higher fungal burden in patients.

Although macrophages are usually protective in the human immune response to infection, in this case the macrophages engulf but are unable to kill the fungus which is then trafficked within them to the brain.

The higher the level of fungus in the brain and spinal fluid in patients, the greater the risk of dying among HIV positive patients with meningitis.

The findings raise the possibility of developing brand new therapies for HIV positive patients that could target macrophages to prevent them transporting the fungus around the body.

Dr Tihana Bicanic, a Senior Lecturer and Clinical Specialist in Infectious Diseases in the Institute for Infection and Immunity at St George's, University of London, said: "Cryptococcal meningitis is the most common and deadly cause of meningitis in patients with suppressed immune systems, particularly in HIV/AIDS.

"We currently only have three antifungal drugs to deploy against this fungus. Studies such as this one improve our understanding of the clever strategies the fungus uses to hide from our immune system and pave the way for identifying potential targets for new antifungals."

Robin May, Professor of Infectious Diseases at the University of Birmingham, said: "This appears to be a remarkable case of a pathogen "hijacking" our own immune system in order to spread around the body.

"By understanding more about the way they do this, we hope to ultimately be able to develop therapies that will help patient immune systems to destroy, rather than protect, the ."

More information: "Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS." Park BJ, et al. AIDS. 2009 Feb 20;23(4):525-30. DOI: 10.1097/QAD.0b013e328322ffac.

"Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis." Wilber Sabiiti, et al. J Clin Invest. DOI: 10.1172/JCI72950.

Related Stories

Breast cancer drug fights fungal disease

date Feb 11, 2014

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more ...

New study finds titan cells protect Cryptococcus

date May 28, 2012

Giant cells called "titan cells" protect the fungus Cryptococcus neoformans during infection, according to two University of Minnesota researchers. Kirsten Nielsen, Ph.D., an assistant professor in the department of microb ...

Recommended for you

HIV reservoirs remain obstacles to cure

date May 19, 2015

Antiretroviral therapy (ART) has proven lifesaving for people infected with HIV; however, the medications are a lifelong necessity for most HIV-infected individuals and present practical, logistical, economic ...

Microclinics help keep Kenyan HIV patients in care

date May 18, 2015

A team led by researchers from UC San Francisco, Organic Health Response, and Microclinic International is reporting results of a study that showed significant benefits of microclinics—an innovative intervention ...

'Redesigned' antibodies may control HIV

date May 18, 2015

With the help of a computer program called "Rosetta," researchers at Vanderbilt University have "redesigned" an antibody that has increased potency and can neutralize more strains of the AIDS-causing human ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.